The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy.
Open accessAbstract
Fibrin II monomer has a dramatic inhibitory effect on the rate of heparin-catalyzed inactivation of human alpha-thrombin by antithrombin III. At 6 microM fibrin II monomer, equivalent to the concentration of fibrinogen in plasma, the second-order rate constant was reduced by a factor of 308--from 2.05 x 10(8) M-1.s-1 to 6.65 x 10(5) M-1.s-1. Fibrin II monomer minimally affected the uncatalyzed rate of thrombin inactivation showing a reduction in the second-order rate constant by a factor of only 1.6. Fibrinogen and the product of plasmin degradation of fibrinogen, fragment E, at 6 microM concentrations also decreased the second-order rate constant for heparin-catalyzed thrombin inactivation, but by factors of only 2.7 and 1.9, respectively. On the basis of these observations it is proposed that protection of thrombin from inactivation by heparin-antithrombin III by fibrin II monomer can explain the limited efficacy of heparin in preventing coronary reocclusion in patients treated with tissue plasminogen activator and other fibrinolytic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A simplified method for cyanogen bromide activation of agarose for affinity chromatography
March, S. C., Parikh, I., & Cuatrecasas, P. (1974) · Analytical Biochemistry · doi:10.1016/0003-2697(74)90139-0 · Cited by 1,935
Esters of Methanesulfonic Acid as Irreversible Inhibitors of Acetylcholinesterase
Kitz, R., & Wilson, I. B. (1962) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50153-8 · Cited by 1,519
Jackson, C. M., & Nemerson, Y. (1980) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.49.070180.004001 · Cited by 565
Self-citationMechanism of the anticoagulant action of heparin
Bj�rk, I., & Lindahl, U. (1982) · Molecular and Cellular Biochemistry · doi:10.1007/bf00421226 · Cited by 494
Tian, W. X., & Tsou, C. L. (1982) · Biochemistry · doi:10.1021/bi00534a031 · Cited by 344
Gold, H. K., Leinbach, R. C., Garabedian, H. D., Yasuda, T., Johns, J. A., Grossbard, E. B., Palacios, I., & Collen, D. (1986) · Circulation · doi:10.1161/01.cir.73.2.347 · Cited by 292
Olson, S. T., Srinivasan, K. R., Björk, I., & Shore, J. D. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68557-1 · Cited by 226
(1988) · KARGER eBooks · doi:10.1159/isbn.978-3-318-01577-5 · Cited by 225
The binding of thrombin by fibrin.
Liu, C. Y., Nossel, H. L., & Kaplan, K. L. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86724-8 · Cited by 219
Thrombin activity of fibrin thrombi and soluble plasmic derivatives.
Francis, C., Markham, R. E., Gh, B., Tm, F., Dm, D., & Marder, V. (1983) · PubMed · Cited by 168
Cited by
Hirsh, J., Warkentin, T. E., Shaughnessy, S. G., Anand, S. S., Halperin, J. L., Raschke, R., Granger, C., Ohman, E. M., & Dalen, J. E. (2001) · Chest · doi:10.1378/chest.119.1_suppl.64s · Cited by 1,580
Weitz, J. I., Hudoba, M., Massel, D., Maraganore, J., & Hirsh, J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114723 · Cited by 1,123
Heparin and Low-Molecular-Weight Heparin
Hirsh, J., Warkentin, T. E., Raschke, R., Granger, C., Ohman, E. M., & Dalen, J. E. (1998) · Chest · doi:10.1378/chest.114.5_supplement.489s · Cited by 1,031
Heparin and Low-Molecular-Weight Heparin
Hirsh, J., & Raschke, R. (2004) · Chest · doi:10.1378/chest.126.3_suppl.188s · Cited by 971
Oates, J. A., Wood, A. J. J., & Hirsh, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105303242206 · Cited by 830
Thrombin generation and fibrin clot structure
Wolberg, A. S. (2007) · Blood Reviews · doi:10.1016/j.blre.2006.11.001 · Cited by 747
Raschke, R. A., Reilly, B. M., Guidry, J. R., Fontana, J. R., & Srinivas, S. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-9-199311010-00002 · Cited by 743
Bode, W., Turk, D., & Karshikov, A. (1992) · Protein Science · doi:10.1002/pro.5560010402 · Cited by 627
Hirsh, J., Anand, S. S., Halperin, J. L., & Fuster, V. (2001) · Circulation · doi:10.1161/01.cir.103.24.2994 · Cited by 565
Bittl, J. A., Strony, J., Brinker, J. A., Ahmed, W. H., Meckel, C. R., Chaitman, B. R., Maraganore, J., Deutsch, E., & Adelman, B. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509213331204 · Cited by 492
A player of many parts: The spotlight falls on thrombin's structure
Stubbs, M. T., & Bode, W. (1993) · Thrombosis Research · doi:10.1016/0049-3848(93)90002-6 · Cited by 441
Glycosaminoglycans and the regulation of blood coagulation
Bourin, M. C., & Lindahl, U. (1993) · Biochemical Journal · doi:10.1042/bj2890313 · Cited by 419
Serpins in thrombosis, hemostasis and fibrinolysis
RAU, J. C., BEAULIEU, L. M., HUNTINGTON, J. A., & CHURCH, F. C. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02516.x · Cited by 347
Griffin, L., Tidmarsh, G., Bock, L., Toole, J., & Leung, L. (1993) · Blood · doi:10.1182/blood.v81.12.3271.3271 · Cited by 285
Optimal Therapeutic Level of Heparin Therapy in Patients With Venous Thrombosis
Hull, R. D. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.8.1589 · Cited by 260
Metadata
- Authors
- Hogg, P. J., & Jackson, C. M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1989-05
- Volume
- 86
- Issue
- 10
- Pages
- 3619-3623
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2085873519
- Cited by
- 347
- References
- 16
- FWCI
- 11.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.